Skip to main content
. 2016 Feb 24;11:9. doi: 10.1186/s13027-016-0056-y

Fig. 4.

Fig. 4

Cumulative incidence of HCC according to insulin resistance (cut-off HOMA-IR 3.0) for non-SVR patients with a low to moderate AFP level (<10 ng/mL) and b high AFP level (≥10 U/L). HCC, hepatocellular carcinoma; HOMA, homeostasis model assessment of insulin resistance; SVR, sustained virological response; AFP, alpha-fetoprotein